Metraipolis › archive › dc_ba447748d650

Design of a Phase 3, Multicenter, Randomized, Open-Label Study of Nipocalimab or IVIG and Prednisone in Pregnancies at Risk for Fetal and Neonatal Alloimmune… — Europe PMC PMID:41290206

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41290206
DOI
10.1055/a-2753-9323
License (as archived)
solo-consultazione
Archived
2026-11-08T06:47:56.655Z
SHA-256 of the archived text
31f71550fc97d513c9a7fcca1ca3bfa11c299b42dc60d5d01bed5f72af6d333a
Stable URL of this page
https://metraipolis.com/documento/dc_ba447748d650

How to cite

Design of a Phase 3, Multicenter, Randomized, Open-Label Study of Nipocalimab or IVIG and Prednisone in Pregnancies at Risk for Fetal and Neonatal Alloimmune… — Europe PMC PMID:41290206 — Europe PMC (en), https://europepmc.org/article/MED/41290206 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ba447748d650 (Metraipolis archive dc_ba447748d650, sha256 31f71550fc97d513c9a7fcca1ca3bfa11c299b42dc60d5d01bed5f72af6d333a)
BibTeX
@misc{dcba447748d650,
  title = {Design of a Phase 3, Multicenter, Randomized, Open-Label Study of Nipocalimab or IVIG and Prednisone in Pregnancies at Risk for Fetal and Neonatal Alloimmune… — Europe PMC PMID:41290206},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41290206},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ba447748d650; sha256 31f71550fc97d513c9a7fcca1ca3bfa11c299b42dc60d5d01bed5f72af6d333a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41290206. Agents can read the archived copy with the MCP tool read_document.